Cargando…
Interpreting Molecular Monitoring Results and International Standardization in Chronic Myeloid Leukemia
Important advances in the understanding of the molecular basis of chronic myeloid leukemia have resulted in the development of new therapies and changed the paradigm for managing this myeloproliferative disease. Translocation of chromosomes 9 and 22 (known as the Philadelphia chromosome) results in...
Autores principales: | Bauer, Stephanie, Romvari, Edie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093320/ https://www.ncbi.nlm.nih.gov/pubmed/25031941 |
Ejemplares similares
-
Guide to Interpreting Disease Responses in Chronic Myeloid Leukemia
por: Galinsky, Ilene, et al.
Publicado: (2012) -
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia
por: Li, Bing, et al.
Publicado: (2014) -
Monitoring imatinib plasma concentrations in chronic myeloid leukemia
por: Martins, Darlize Hübner, et al.
Publicado: (2011) -
Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators
por: Ruiz, M S, et al.
Publicado: (2016) -
Issues in current management of chronic myeloid leukemia: Importance of molecular monitoring on long term outcome
por: Menon, Hari
Publicado: (2013)